| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 78,3 M € | +6.2% | 73,8 M € | +6.9% | 69,0 M € | +0.1% | 69,0 M € | -5.8% | 73,2 M € | +17.9% | 62,0 M € | -1.3% | 62,9 M € | +0.2% | 62,7 M € | +1.3% | 62,0 M € | -6.7% | 66,4 M € | +2.0% | 65,1 M € | +4.8% | 62,1 M € | +2.4% | 60,6 M € | +2.8% | 59,0 M € | +5.0% | 56,2 M € | -7.7% | 60,9 M € | +2.3% | 59,5 M € | +12.8% | 52,8 M € | |
| EBITDA | 11,2 M € | +1.6% | 11,0 M € | +47.2% | 7,5 M € | +16.8% | 6,4 M € | -47.8% | 12,3 M € | +12.1% | 11,0 M € | +8.7% | 10,1 M € | +22.4% | 8,3 M € | +12.9% | 7,3 M € | -8.2% | 8,0 M € | +22.8% | 6,5 M € | +221.8% | 2,0 M € | +561.0% | 305,1 k € | +42.6% | 214,0 k € | +180.5% | -265,9 k € | -104.8% | 5,5 M € | +36.0% | 4,1 M € | +38.1% | 3,0 M € | |
| Operating profit | 10,2 M € | +1.1% | 10,1 M € | +53.9% | 6,6 M € | +9.1% | 6,0 M € | -43.3% | 10,6 M € | +12.3% | 9,5 M € | +5.0% | 9,0 M € | +25.3% | 7,2 M € | +24.5% | 5,8 M € | -22.5% | 7,5 M € | +39.1% | 5,4 M € | +488.4% | 910,6 k € | +209.3% | -833,1 k € | +11.4% | -940,1 k € | +21.2% | -1,2 M € | -124.5% | 4,9 M € | +57.0% | 3,1 M € | +49.8% | 2,1 M € | |
| Profit/loss | 7,9 M € | -0.3% | 8,0 M € | +55.0% | 5,1 M € | +23.5% | 4,2 M € | -45.8% | 7,7 M € | +12.2% | 6,9 M € | +14.1% | 6,0 M € | +26.6% | 4,7 M € | +38.3% | 3,4 M € | -28.4% | 4,8 M € | +42.8% | 3,4 M € | +142.9% | 1,4 M € | +266.4% | -830,7 k € | +21.9% | -1,1 M € | +5.3% | -1,1 M € | -136.5% | 3,1 M € | +57.5% | 2,0 M € | +39.4% | 1,4 M € | |
| Equity | 33,9 M € | -30.7% | 49,0 M € | +19.4% | 41,0 M € | +14.3% | 35,9 M € | +13.1% | 31,7 M € | +32.1% | 24,0 M € | +40.0% | 17,1 M € | -14.8% | 20,1 M € | +30.9% | 15,4 M € | +28.7% | 11,9 M € | -46.1% | 22,2 M € | +17.9% | 18,8 M € | +7.9% | 17,4 M € | -4.6% | 18,2 M € | -5.5% | 19,3 M € | -5.5% | 20,4 M € | +17.7% | 17,4 M € | +47.4% | 11,8 M € | |
| Total assets | 48,6 M € | -23.6% | 63,6 M € | +13.3% | 56,1 M € | +9.2% | 51,4 M € | +15.8% | 44,4 M € | +28.3% | 34,6 M € | +35.6% | 25,5 M € | -13.9% | 29,6 M € | +7.6% | 27,5 M € | -32.2% | 40,6 M € | +24.0% | 32,7 M € | +3.7% | 31,6 M € | +18.3% | 26,7 M € | -8.7% | 29,2 M € | +3.9% | 28,1 M € | -7.9% | 30,5 M € | +18.0% | 25,9 M € | +23.6% | 20,9 M € | |
| Cash | 1,3 M € | -5.2% | 1,4 M € | +33.0% | 1,0 M € | +48.5% | 699,4 k € | -54.0% | 1,5 M € | +26.2% | 1,2 M € | -7.4% | 1,3 M € | +16.4% | 1,1 M € | -28.7% | 1,6 M € | +31.1% | 1,2 M € | +3.0% | 1,2 M € | +82.9% | 635,1 k € | -28.1% | 883,1 k € | -29.8% | 1,3 M € | -39.1% | 2,1 M € | +21.8% | 1,7 M € | +10.8% | 1,5 M € | -6.7% | 1,6 M € | |
| Debts | 14,3 M € | -1.7% | 14,6 M € | -2.6% | 15,0 M € | -1.9% | 15,3 M € | +24.6% | 12,2 M € | +21.8% | 10,1 M € | +26.1% | 8,0 M € | -12.2% | 9,1 M € | -19.1% | 11,2 M € | -60.2% | 28,2 M € | +176.3% | 10,2 M € | -19.6% | 12,7 M € | +37.2% | 9,3 M € | -15.4% | 10,9 M € | +24.4% | 8,8 M € | -12.7% | 10,1 M € | +18.8% | 8,5 M € | -4.1% | 8,8 M € | |
| Staff | 140,1 | 141,3 | 142 | 150,9 | 151,2 | 153,9 | 167,1 | 176,2 | 179,5 | 179,8 | 182 | 197,4 | 204,1 | 198,4 | 197,4 | 196,3 | 149,7 | 145,7 | ||||||||||||||||||
Public limited company · Machelen (Brab.) · incorporated on 02/12/1958 · 140,1 ETP
Public limited company profitable and well capitalised. Cash position declining (-5.2%).
Solid counterparty for a standard engagement.
MENARINI BENELUX is a Public limited company incorporated in 1958. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 140,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette